← Back to Search

MOSAIC Plus for Intimate Partner Violence (MOSAIC Plus Trial)

N/A
Waitlist Available
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have elevated depressive and/or PTSD symptoms as assessed by Patient Health Questionnaire (PHQ-9) with a cutoff point of ≥9, and/or the Davidson Trauma Scale (DTS) with a cut-off point of ≥40.
Aged 18 or above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6 and 9 months
Awards & highlights

MOSAIC Plus Trial Summary

This trial aims to test a new program (MOSAIC Plus) to reduce depression and PTSD in pregnant women and mothers who experience IPV. It will enroll those who screen positive for elevated symptoms and last 6 months.

Who is the study for?
This trial is for pregnant women or mothers with children under 5 who have faced intimate partner violence (IPV) in the last 6 months and are showing signs of depression or PTSD. Participants must be over 18, able to provide contact info for two people who can locate them, and understand English well enough for consent and assessments.Check my eligibility
What is being tested?
The MOSAIC Plus intervention is being tested to see if it helps reduce symptoms of depression and PTSD while preventing further IPV. It combines interpersonal therapy techniques with the existing MOSAIC support program over a period of six months after joining the study.See study design
What are the potential side effects?
Since this trial involves psychological support interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, discussing traumatic experiences could potentially lead to temporary increases in distress.

MOSAIC Plus Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have significant depression or PTSD symptoms.
Select...
I am 18 years old or older.

MOSAIC Plus Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6 and 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6 and 9 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Working Relationship
Reduction in Posttraumatic Stress Disorder Symptoms
Reduction in depressive symptoms
+2 more
Secondary outcome measures
Effectiveness Obtaining Resources
Functioning
General health and wellbeing
+3 more
Other outcome measures
Provider Competencies
Quality of working relationship-provider perspective

MOSAIC Plus Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MOSAIC PlusExperimental Treatment1 Intervention
"Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.
Group II: MOSAICActive Control1 Intervention
Those in the active comparator will receive the "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV.

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
184 Previous Clinical Trials
601,367 Total Patients Enrolled

Media Library

MOSAIC Clinical Trial Eligibility Overview. Trial Name: NCT05106361 — N/A
Domestic Violence Research Study Groups: MOSAIC, MOSAIC Plus
Domestic Violence Clinical Trial 2023: MOSAIC Highlights & Side Effects. Trial Name: NCT05106361 — N/A
MOSAIC 2023 Treatment Timeline for Medical Study. Trial Name: NCT05106361 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been accepted to this medical experiment?

"Affirmative. According to the information available on clinicaltrials.gov, this research is actively recruiting participants since it was first posted on July 14th 2023 and has been recently updated with the same date. The experiment seeks 40 individuals across one location for participation."

Answered by AI

What goals does this clinical trial hope to accomplish?

"This 9-month medical trial intends to gauge the Satisfaction with care of participating patients. Additionally, Effectiveness Obtaining Resources (EOR) scale and WHO Disability Assessment schedule-12 will be used to measure Functioning as well as Self-care and self-worth via a respective scale."

Answered by AI

Are there still opportunities for people to participate in this research endeavor?

"Correct. Information found on clinicaltrials.gov demonstrates that this study is currently gathering participants, having first been posted and most recently modified on July 14th 2023. The trial requires 40 people to be tested at one medical centre."

Answered by AI
~25 spots leftby Sep 2024